Stereotaxis Introduces GenesisX at RSNA 2024
ST. LOUIS and SHENYANG, China — Stereotaxis (NYSE: STXS) and Neusoft Medical Systems have announced an exciting collaboration, unveiling the GenesisX robotic system at the annual Radiology Society of North America (RSNA) meeting. This prestigious event attracts over 50,000 participants from more than 150 countries, making it an ideal platform for groundbreaking medical innovations.
GenesisX: Revolutionizing Endovascular Procedures
For the first time, the GenesisX system, a cutting-edge advancement in endovascular robotic technology, will be on display. It is being showcased alongside Neusoft Medical Systems' NeuAngio 30F fluoroscopy system. This collaboration signifies a commitment to merging complementary technologies that enhance precision and safety in medical procedures.
Why GenesisX Stands Out
The GenesisX system builds on the established advantages of Robotic Magnetic Navigation technology. This innovation is designed to simplify the transition and integration within healthcare facilities, aiming to improve patient outcomes through enhanced procedural accuracy and efficiency.
Leadership Perspectives on Collaboration
Patrick Wu, CEO of Neusoft Medical Systems, expressed enthusiasm about this partnership, highlighting their shared goal of providing superior healthcare solutions globally. He stated, "Stereotaxis’ revolutionary GenesisX robotic technology fits seamlessly into our portfolio of advanced imaging systems."
Stereotaxis' Vision and Impact
David Fischel, CEO of Stereotaxis, also shared his excitement about showcasing their technology at such a significant conference. He remarked, "GenesisX promises to profoundly impact endovascular robotics, and our collaboration with Neusoft Medical Systems is crucial in delivering innovative technologies to healthcare providers around the world."
About Stereotaxis
Stereotaxis (NYSE: STXS) is recognized as a pioneer in surgical robotics focused on minimally invasive endovascular interventions. Their mission centers on innovating robotic systems, instruments, and information technology intended for interventional laboratories. This technology has already transformed the care of over 150,000 patients globally, underlining the company's commitment to improving the quality of healthcare through cutting-edge robotics.
Long-Term Aspirations and Achievements
The innovations introduced by Stereotaxis are not merely technological advancements; they represent a dedication to enhancing patient safety and expanding access to less invasive therapies. By integrating connectivity and intelligence into operating rooms, Stereotaxis aims to enhance productivity and improve outcomes in surgical procedures.
Future Innovations on the Horizon
As Stereotaxis continues to develop and expand its robotic systems, their partnership with Neusoft Medical Systems will likely lead to new heights in medical technology. This collaboration reflects a shared passion for creativity and excellence in the healthcare sector, ensuring that patients receive the best care possible.
Frequently Asked Questions
What is GenesisX?
The GenesisX is a robotic system developed by Stereotaxis designed to enhance precision and efficiency in endovascular procedures.
Where is GenesisX being showcased?
GenesisX is being unveiled at the RSNA 2024 annual meeting in collaboration with Neusoft Medical Systems.
What is Stereotaxis' role in the medical field?
Stereotaxis is a leader in surgical robotics, focusing on innovations to improve minimally invasive interventions.
How does the GenesisX system improve healthcare?
The GenesisX system enhances procedural safety and accuracy, making it easier for hospitals to adopt robotic technologies.
What future innovations can we expect from Stereotaxis?
As Stereotaxis continues to innovate, they will likely introduce further advancements in robotic systems and technologies aimed at improving patient care.
